Targeting of p53-Transcriptional Dysfunction by Conditionally Replicating Adenovirus Is Not Limited by p53-Homologues
Open Access
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (5) , 936-946
- https://doi.org/10.1038/mt.2009.298
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- E4orf1 Limits the Oncolytic Potential of the E1B - 55K Deletion Mutant AdenovirusJournal of Virology, 2009
- TAp73 knockout shows genomic instability with infertility and tumor suppressor functionsGenes & Development, 2008
- Adenovirus E1B55K Region Is Required To Enhance Cyclin E Expression for Efficient Viral DNA ReplicationJournal of Virology, 2008
- TAp63α induces apoptosis by activating signaling via death receptors and mitochondriaThe EMBO Journal, 2005
- Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenovirusesMolecular Therapy, 2005
- New antibodies recognizing p73: Comparison with commercial antibodiesBiochemical and Biophysical Research Communications, 2005
- Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathwaysCancer Gene Therapy, 2003
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- The p53 gene familyOncogene, 1999
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994